Liposome-encapsulated antibiotics

Isam I Salem1, Diana L Flasher, Nejat Düzgüneş

  • 1Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, Spain.

Methods in Enzymology
|February 22, 2005
PubMed

Insights

Liposome encapsulation enhances antibiotic efficacy against Mycobacterium avium-intracellulare complex (MAC) infections in cells and animal models. This study evaluates various liposomal antibiotics, including sparfloxacin and azithromycin, for improved MAC treatment.

Area of Science:

  • Pharmacology and Drug Delivery
  • Microbiology and Infectious Diseases
  • Biotechnology and Nanomedicine

Background:

  • Liposome encapsulation is a promising strategy to improve antibiotic delivery and efficacy.
  • Mycobacterium avium-intracellulare complex (MAC) infections pose significant challenges, particularly in immunocompromised individuals.
  • Current treatments for MAC infections often face limitations in efficacy and require prolonged therapy.

Purpose of the Study:

  • To evaluate the efficacy of various antibiotics encapsulated in liposomes against MAC infections.
  • To investigate the potential of pH-sensitive liposomes for enhanced drug delivery in MAC disease models.
  • To explore liposomal formulations of antibiotics for treating MAC and other mycobacterial infections.

Main Methods:

  • Incorporation of antibiotics (amikacin, streptomycin, ciprofloxacin, sparfloxacin, clarithromycin) into diverse liposomal formulations.
  • In vitro evaluation of liposomal antibiotic efficacy against MAC in macrophage cell cultures.
  • In vivo assessment using the beige mouse model of MAC disease and studies with Mycobacterium tuberculosis models.

Main Results:

  • Liposomal encapsulation demonstrated enhanced efficacy of tested antibiotics against MAC infections.
  • pH-sensitive liposomes incorporating sparfloxacin or azithromycin showed promising results in MAC models.
  • Studies with other antibiotics (rifampicin, isoniazid, etc.) in liposomal form were summarized, indicating broad applicability.

Conclusions:

  • Liposome-encapsulated antibiotics represent a viable strategy to improve treatment outcomes for MAC infections.
  • The development of targeted liposomal drug delivery systems offers a promising avenue for combating mycobacterial diseases.
  • Further research into liposomal antibiotic formulations could lead to more effective therapies for challenging infections.

Related Concept Videos

Lysosomes01:31

Lysosomes

Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...